Login / Signup

Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.

Shaoli LiChenyue XuShaohua HuJianbo Lai
Published in: European psychiatry : the journal of the Association of European Psychiatrists (2024)
Keyphrases
  • depressive symptoms
  • bipolar disorder
  • open label
  • sleep quality
  • randomized controlled trial
  • drug administration
  • placebo controlled